01.12.2006 | Original Article
Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer
Erschienen in: Medical Oncology | Ausgabe 4/2006
Einloggen, um Zugang zu erhalten